mRNA-based influenza vaccine expands the B cell response breadth in humans
Nat Immunol. 2026 Jun 15. doi: 10.1038/s41590-026-02569-5. Online ahead of print.
PMID:
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adults
EBioMedicine. 2026 Jun 12;129:106321. doi: 10.1016/j.ebiom.2026.106321. Online ahead of print.
PMID:
Vaccines and therapeutics for Andes hantavirus
Npj Viruses. 2026 Jun 9;4(1):29. doi: 10.1038/s44298-026-00200-w.
PMID:
Andes hantavirus – A primer
Npj Viruses. 2026 Jun 5;4(1):27. doi: 10.1038/s44298-026-00201-9.
PMID:
Seroprevalence of IgM and IgG Antibodies Directed Against Hepatitis E Virus in 4867 Blood Donors From Tyrol, Austria
J Med Virol. 2026 Jun;98(6):e70991. doi: 10.1002/jmv.70991.
PMID:
Privacy-Preserving Self-Registration to a Large-Scale Randomised Controlled Clinical Screening Trial in Austria
Stud Health Technol Inform. 2026 May 21;336:1875-1879. doi: 10.3233/SHTI260563.
PMID:
Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025
Euro Surveill. 2026 May;31(20):2600375. doi: 10.2807/1560-7917.ES.2026.31.20.2600375.
PMID:
SARS-CoV-2 Delta, not Omicron, drives Transferrin receptor-1 upregulation, inflammatory activation, and viral persistence in macrophages
Biomed Pharmacother. 2026 May 14;200:119474. doi: 10.1016/j.biopha.2026.119474. Online ahead of print.
PMID:
What’s in a NAM?
Lab Anim (NY). 2026 May 13. doi: 10.1038/s41684-026-01731-8. Online ahead of print.
PMID:
Virtual reality for pain and anxiety reduction during venous puncture procedures : AÂ within-subject clinical crossover study
Wien Klin Wochenschr. 2026 May 8. doi: 10.1007/s00508-026-02763-3. Online ahead of print.
PMID: